nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR1E—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.0072	0.0072	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00688	0.00688	CbGpPWpGaD
Methylergometrine—HTR2B—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00684	0.00684	CbGpPWpGaD
Methylergometrine—HTR1F—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00682	0.00682	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00669	0.00669	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00666	0.00666	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00653	0.00653	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00649	0.00649	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00646	0.00646	CbGpPWpGaD
Methylergometrine—HTR1E—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00643	0.00643	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00627	0.00627	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00616	0.00616	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00612	0.00612	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00604	0.00604	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00589	0.00589	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00587	0.00587	CbGpPWpGaD
Methylergometrine—HTR2B—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.0058	0.0058	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00561	0.00561	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00556	0.00556	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00555	0.00555	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00553	0.00553	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00552	0.00552	CbGpPWpGaD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00542	0.00542	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0054	0.0054	CbGpPWpGaD
Methylergometrine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00529	0.00529	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00524	0.00524	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00519	0.00519	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00511	0.00511	CbGpPWpGaD
Methylergometrine—DRD1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00499	0.00499	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00497	0.00497	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00494	0.00494	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00482	0.00482	CbGpPWpGaD
Methylergometrine—HTR2B—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00482	0.00482	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00479	0.00479	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00475	0.00475	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00469	0.00469	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00469	0.00469	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00468	0.00468	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00453	0.00453	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00449	0.00449	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00434	0.00434	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00431	0.00431	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00431	0.00431	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00429	0.00429	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00427	0.00427	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00427	0.00427	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00423	0.00423	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00419	0.00419	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00413	0.00413	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00413	0.00413	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00409	0.00409	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00407	0.00407	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00407	0.00407	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00406	0.00406	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00394	0.00394	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00392	0.00392	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00391	0.00391	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00389	0.00389	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00388	0.00388	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00384	0.00384	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00384	0.00384	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00374	0.00374	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00371	0.00371	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00371	0.00371	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00369	0.00369	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00366	0.00366	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00363	0.00363	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00363	0.00363	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00362	0.00362	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00362	0.00362	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00353	0.00353	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00347	0.00347	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00345	0.00345	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00342	0.00342	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00337	0.00337	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00332	0.00332	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.0033	0.0033	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00329	0.00329	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00325	0.00325	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00319	0.00319	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00317	0.00317	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00316	0.00316	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00314	0.00314	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00313	0.00313	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00311	0.00311	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.0031	0.0031	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00302	0.00302	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00301	0.00301	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00301	0.00301	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00298	0.00298	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00293	0.00293	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00284	0.00284	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00281	0.00281	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00278	0.00278	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00276	0.00276	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00269	0.00269	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00265	0.00265	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00257	0.00257	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00255	0.00255	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00255	0.00255	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00254	0.00254	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00243	0.00243	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00242	0.00242	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0024	0.0024	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00236	0.00236	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00233	0.00233	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00232	0.00232	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00231	0.00231	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0023	0.0023	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00229	0.00229	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00226	0.00226	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00223	0.00223	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0022	0.0022	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0022	0.0022	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00217	0.00217	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00213	0.00213	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00212	0.00212	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00208	0.00208	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00206	0.00206	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00205	0.00205	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00205	0.00205	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00201	0.00201	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.002	0.002	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00196	0.00196	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00195	0.00195	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00193	0.00193	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00184	0.00184	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00183	0.00183	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00183	0.00183	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00177	0.00177	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00175	0.00175	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00172	0.00172	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.0017	0.0017	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00161	0.00161	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00157	0.00157	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00156	0.00156	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00156	0.00156	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00143	0.00143	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00139	0.00139	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00136	0.00136	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00136	0.00136	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00133	0.00133	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00131	0.00131	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00128	0.00128	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00116	0.00116	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00116	0.00116	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00111	0.00111	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0011	0.0011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.0011	0.0011	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00108	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00105	0.00105	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00105	0.00105	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00101	0.00101	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000987	0.000987	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000962	0.000962	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000961	0.000961	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000959	0.000959	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000953	0.000953	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000923	0.000923	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000908	0.000908	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000887	0.000887	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000873	0.000873	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000861	0.000861	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000844	0.000844	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000836	0.000836	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000815	0.000815	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000812	0.000812	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000801	0.000801	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000769	0.000769	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000737	0.000737	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000736	0.000736	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000733	0.000733	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000716	0.000716	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000695	0.000695	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000694	0.000694	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000694	0.000694	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00068	0.00068	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000658	0.000658	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000641	0.000641	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000621	0.000621	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000607	0.000607	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000603	0.000603	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000594	0.000594	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000573	0.000573	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000571	0.000571	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000566	0.000566	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000549	0.000549	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000534	0.000534	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000516	0.000516	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000477	0.000477	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000458	0.000458	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000457	0.000457	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000434	0.000434	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000409	0.000409	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000403	0.000403	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000397	0.000397	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000371	0.000371	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000357	0.000357	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00035	0.00035	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000337	0.000337	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000304	0.000304	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000288	0.000288	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	0.000279	0.000279	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00025	0.00025	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	0.000239	0.000239	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	0.000183	0.000183	CbGpPWpGaD
